Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Drug repositioning for post cardiopulmonary resuscitation syndrome using large-scale medical claims
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-DDD-008
- By: ZAMAMI, Yoshito (Tokushima University Graduate School of Biomedical Sciences, Clinical Pharmacology and Therapeutics)
- Co-author(s): Yoshito Zamami: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Pharmacy, Tokushima University Hospital, Tokushima, Japan
Yuki Izawa-Ishizawa: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
Takahiro Niimura: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
Masaki Imanishi: Pharmacy, Tokushima University Hospital, Tokushima, Japan
Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
Yuya Horinouchi: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
Yasumasa Ikeda: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
Koichiro Tsuchiya: Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
Keisuke Ishizawa: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Pharmacy, Tokushima University Hospital, Tokushima, Japan - Abstract:
Background
Worldwide, approximately one hundred million people develop cardiac arrest every year, and the survival rate is very low. Therefore, the development of novel drug for post cardiopulmonary resuscitation syndrome is desirable. In recent years, drug repositioning has been proposed as a strategy for developing existing drugs as therapeutic.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023